atrial septal defect; left atrial appendage; percutaneous closure; surgical closure; Atrial Fibrillation; Cardiac Catheterization; Echocardiography, Transesophageal; Foramen Ovale, Patent; Humans; Predictive Value of Tests; Treatment Outcome; Atrial Appendage/diagnostic imaging; Heart Septal Defects, Atrial; Atrial Appendage; Radiology, Nuclear Medicine and Imaging; Cardiology and Cardiovascular Medicine
Abstract :
[en] This review comprises 2 main subjects: the percutaneous and surgical closure of the left atrial appendage (LAA) and atrial septal defect (ASD). The aim of the authors was to provide a detailed description of: 1) anatomy of LAA, normal interatrial septum, and the various types of ASD as revealed by noninvasive imaging techniques; 2) preprocedure planning of secundum ASD and LAA percutaneous closure; 3) key steps of the procedural guidance emphasizing the role of 2-dimensional/3-dimensional transesophageal echocardiography; and 4) surgical closure of LAA and ASD.
Dr. Faletra has performed several talks supported by Philips. Dr. Saric is on the Speakers Bureau of Philips and Medtronic and on Siemens’ Advisory Board. Dr. Saw has received unrestricted research grant support from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, National Institutes of Health, University of British Columbia Division of Cardiology, AstraZeneca, Abbott Vascular, Boston Scientific, and Servier; speaker honoraria from AstraZeneca, Abbott Vascular, Boston Scientific, Bayer, and Sunovion; consultancy and Advisory Board honoraria from AstraZeneca, Boston Scientific, and Abbott Vascular; and proctorship honoraria from Abbott Vascular and Boston Scientific. Dr. Hanke has received travel expenses from and is a consultant for Atricure, U.S.A. (receiving <$10,000 per year). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.Dr. Faletra has performed several talks supported by Philips. Dr. Saric is on the Speakers Bureau of Philips and Medtronic and on Siemens’ Advisory Board. Dr. Saw has received unrestricted research grant support from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, National Institutes of Health, University of British Columbia Division of Cardiology, AstraZeneca, Abbott Vascular, Boston Scientific, and Servier; speaker honoraria from AstraZeneca, Abbott Vascular, Boston Scientific, Bayer, and Sunovion; consultancy and Advisory Board honoraria from AstraZeneca, Boston Scientific, and Abbott Vascular; and proctorship honoraria from Abbott Vascular and Boston Scientific. Dr. Hanke has received travel expenses from and is a consultant for Atricure, U.S.A. (receiving <$10,000 per year). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Veinot, J.P., Harrity, P.J., Gentile, F., et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation 96 (1997), 3112–3115.
Di Biase, L., Santangeli, P., Anselmino, M., et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol 60 (2012), 531–538.
Cabrera, J.A., Ho, S.Y., Climent, V., Sanchez-Quintana, D., The architecture of the left lateral atrial wall: a particular anatomic region with implications for ablation of atrial fibrillation. Eur Heart J 29 (2008), 356–362.
Pritchett, E.L., Management of atrial fibrillation. N Engl J Med, 326, 1992, 1264.
Holmes, D.R., Reddy, V.Y., Turi, Z.G., et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non-inferiority trial. PROTECT AF Investigators. Lancet 374 (2009), 534–542.
Hanke, T., Surgical management of the left atrial appendage: a must or a myth?. Eur J Cardiothorac Surg 53 Suppl 1 (2018), i33–i38.
Lam, Y.Y., Yip, G.W., Yu, C.M., et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv 79 (2012), 794–800.
Cruz-Gonzalez, I., Perez-Rivera, A., Lopez-Jimenez, R., et al. Significance of the learning curve in left atrial appendage occlusion with two different devices. Catheter Cardiovasc Interv 83 (2013), 642–646.
Freixa, X., Chan, J., Tzikas, A., Garceau, P., Basmadjian, A., Ibrahim, R., The Amplatzer™ Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience. EuroIntervention 8 (2013), 1094–1098.
Suwalski, P., Witkowska, A., Drobiński, D., et al. Stand-alone totally thoracoscopic left atrial appendage exclusion using a novel clipping system in patients with high risk of stroke - initial experience and literature review. Kardiochir Torakochirurgia Pol 12 (2015), 298–303.
Faletra, F.F., Nucifora, G., Ho, S.Y., Imaging the atrial septum using real-time three-dimensional transesophageal echocardiography: technical tips, normal anatomy and its role in transseptal puncture. J Am Soc Echocardiogr 24 (2011), 593–599.
Saric, M., Perk, G., Purgess, J., Kronzon, I., Imaging atrial septal defects by real-time 3D transesophageal echocardiography: step-by-step approach. J Am Soc Echocardiogr 23 (2010), 1128–1135.
Faletra, F.F., Ramamurthi, A., Dequarti, M.C., Leo, L.A., Moccetti, T., Pandian, N., Artifacts in three-dimensional transesophageal echocardiography. J Am Soc Echocardiogr 27 (2014), 453–462.
